📗 Cite This Artifact
Section 249: Advanced LSVT Voice and Speech Therapy in CBS/PSP
Section 249: Advanced LSVT Voice and Speech Therapy in CBS/PSP
Overview
<table class="infobox infobox-therapeutic">
<tr>
<th class="infobox-header" colspan="2">Section 249: Advanced LSVT Voice and Speech Therapy in CBS/PSP</th>
</tr>
<tr>
<td class="label">Parameter</td>
<td>Specification</td>
</tr>
<tr>
<td class="label">Duration</td>
<td>4 weeks (1 month)</td>
</tr>
<tr>
<td class="label">Session Frequency</td>
<td>4 sessions per week</td>
</tr>
<tr>
<td class="label">Session Length</td>
<td>45-60 minutes</td>
</tr>
<tr>
<td class="label">Total Sessions</td>
<td>16 sessions</td>
</tr>
<tr>
<td class="label">Setting</td>
<td>In-person, individual treatment</td>
</tr>
<tr>
<td class="label">Homework</td>
<td>Daily practice exercises</td>
</tr>
<tr>
<td class="label">Study</td>
<td>Population</td>
</tr>
<tr>
<td class="label">Ramig et al. 2021</td>
<td>PSP</td>
</tr>
<tr>
<td class="label">Fedor et al. 2016</td>
<td>CBS/PSP</td>
</tr>
<tr>
<td class="label">Fox et al. 2012</td>
<td>PD</td>
</tr>
<tr>
<td class="label">Ward et al.
Section 249: Advanced LSVT Voice and Speech Therapy in CBS/PSP
Overview
<table class="infobox infobox-therapeutic">
<tr>
<th class="infobox-header" colspan="2">Section 249: Advanced LSVT Voice and Speech Therapy in CBS/PSP</th>
</tr>
<tr>
<td class="label">Parameter</td>
<td>Specification</td>
</tr>
<tr>
<td class="label">Duration</td>
<td>4 weeks (1 month)</td>
</tr>
<tr>
<td class="label">Session Frequency</td>
<td>4 sessions per week</td>
</tr>
<tr>
<td class="label">Session Length</td>
<td>45-60 minutes</td>
</tr>
<tr>
<td class="label">Total Sessions</td>
<td>16 sessions</td>
</tr>
<tr>
<td class="label">Setting</td>
<td>In-person, individual treatment</td>
</tr>
<tr>
<td class="label">Homework</td>
<td>Daily practice exercises</td>
</tr>
<tr>
<td class="label">Study</td>
<td>Population</td>
</tr>
<tr>
<td class="label">Ramig et al. 2021</td>
<td>PSP</td>
</tr>
<tr>
<td class="label">Fedor et al. 2016</td>
<td>CBS/PSP</td>
</tr>
<tr>
<td class="label">Fox et al. 2012</td>
<td>PD</td>
</tr>
<tr>
<td class="label">Ward et al. 2017</td>
<td>Neurodegenerative</td>
</tr>
<tr>
<td class="label">Standard Parameter</td>
<td>CBS Modification</td>
</tr>
<tr>
<td class="label">Session length</td>
<td>30-45 minutes</td>
</tr>
<tr>
<td class="label">Session frequency</td>
<td>3x/week</td>
</tr>
<tr>
<td class="label">Treatment duration</td>
<td>8-12 weeks</td>
</tr>
<tr>
<td class="label">Rest breaks</td>
<td>Mid-session 5-min break</td>
</tr>
<tr>
<td class="label">Scheduling</td>
<td>Morning sessions</td>
</tr>
<tr>
<td class="label">Challenge</td>
<td>LSVT Modification</td>
</tr>
<tr>
<td class="label">Vertical gaze palsy</td>
<td>Remove仰卧 exercises requiring vertical gaze</td>
</tr>
<tr>
<td class="label">Eye contact difficulty</td>
<td>Use auditory rather than visual cues</td>
</tr>
<tr>
<td class="label">Blepharospasm</td>
<td>Reduce bright lighting during sessions</td>
</tr>
<tr>
<td class="label">Light sensitivity</td>
<td>Adjust room lighting, avoid fluorescents</td>
</tr>
<tr>
<td class="label">Device Type</td>
<td>Features</td>
</tr>
<tr>
<td class="label">Portable amplifier</td>
<td>Battery-operated, wireless microphone</td>
</tr>
<tr>
<td class="label">Desktop amplifier</td>
<td>Plug-in, speaker</td>
</tr>
<tr>
<td class="label">Speech-generating device with amp</td>
<td>AAC + amplification</td>
</tr>
<tr>
<td class="label">Smartphone app</td>
<td>Software-based amplification</td>
</tr>
<tr>
<td class="label">Exercise</td>
<td>Target</td>
</tr>
<tr>
<td class="label">Sustained /s/</td>
<td>Precise sibilant production</td>
</tr>
<tr>
<td class="label">Sustained /ʃ/</td>
<td>Precise fricative production</td>
</tr>
<tr>
<td class="label">Vowel-consonant-vowel</td>
<td>Clear vowel transitions</td>
</tr>
<tr>
<td class="label">Rapid syllable repetition</td>
<td>Motor planning</td>
</tr>
<tr>
<td class="label">Word minimal contrasts</td>
<td>Phonemic contrast</td>
</tr>
<tr>
<td class="label">Contrast</td>
<td>Examples</td>
</tr>
<tr>
<td class="label">/s/ vs /ʃ/</td>
<td>sip-ship, sue-shower</td>
</tr>
<tr>
<td class="label">/t/ vs /k/</td>
<td>tip-keep, tea-key</td>
</tr>
<tr>
<td class="label">/f/ vs /θ/</td>
<td>fan-than, fine-thine</td>
</tr>
<tr>
<td class="label">Vowel length</td>
<td>beet-bit, bad-bed</td>
</tr>
<tr>
<td class="label">Level</td>
<td>Examples</td>
</tr>
<tr>
<td class="label">Basic alphabet board</td>
<td>Letter, word prediction</td>
</tr>
<tr>
<td class="label">Picture/photograph boards</td>
<td>Core vocabulary photos</td>
</tr>
<tr>
<td class="label">Topic boards</td>
<td>Context-specific vocabulary</td>
</tr>
<tr>
<td class="label">Communication books</td>
<td>Personalized phrase book</td>
</tr>
<tr>
<td class="label">System</td>
<td>Input Method</td>
</tr>
<tr>
<td class="label">Grid 3</td>
<td>Touch, eye gaze, scanning</td>
</tr>
<tr>
<td class="label">Tobii Dynavox</td>
<td>Eye gaze</td>
</tr>
<tr>
<td class="label">Accent</td>
<td>Touch, keyguard</td>
</tr>
<tr>
<td class="label">Proloquo2Go</td>
<td>Touch</td>
</tr>
<tr>
<td class="label">Phase</td>
<td>Timeline</td>
</tr>
<tr>
<td class="label">Assessment</td>
<td>Week 1</td>
</tr>
<tr>
<td class="label">Selection</td>
<td>Week 2</td>
</tr>
<tr>
<td class="label">Training</td>
<td>Weeks 3-6</td>
</tr>
<tr>
<td class="label">Generalization</td>
<td>Weeks 7-8</td>
</tr>
<tr>
<td class="label">Follow-up</td>
<td>Ongoing</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Implementation</td>
</tr>
<tr>
<td class="label">Reduce background noise</td>
<td>Turn off TV/radio during conversation</td>
</tr>
<tr>
<td class="label">Optimize lighting</td>
<td>Ensure face is well-lit, no backlighting</td>
</tr>
<tr>
<td class="label">Face-to-face positioning</td>
<td>Position to enable lip-reading</td>
</tr>
<tr>
<td class="label">Quiet spaces</td>
<td>Use quiet areas for important conversations</td>
</tr>
<tr>
<td class="label">Adequate time</td>
<td>Allow extra time for responses</td>
</tr>
<tr>
<td class="label">Requirement</td>
<td>Specification</td>
</tr>
<tr>
<td class="label">Internet</td>
<td>Minimum 5 Mbps upload/download</td>
</tr>
<tr>
<td class="label">Device</td>
<td>Tablet or computer with camera</td>
</tr>
<tr>
<td class="label">Audio</td>
<td>External microphone recommended</td>
</tr>
<tr>
<td class="label">Software</td>
<td>HIPAA-compliant video platform</td>
</tr>
<tr>
<td class="label">Environment</td>
<td>Private, quiet, well-lit space</td>
</tr>
<tr>
<td class="label">App</td>
<td>Function</td>
</tr>
<tr>
<td class="label">LSVT Companion</td>
<td>Practice exercises, feedback</td>
</tr>
<tr>
<td class="label">Voice Meter</td>
<td>Real-time volume monitoring</td>
</tr>
<tr>
<td class="label">Metronome</td>
<td>Tempo control</td>
</tr>
<tr>
<td class="label">BigLauncher</td>
<td>Simplified phone interface</td>
</tr>
<tr>
<td class="label">Professional</td>
<td>Role</td>
</tr>
<tr>
<td class="label">Speech-Language Pathologist</td>
<td>Primary treatment</td>
</tr>
<tr>
<td class="label">Neurologist</td>
<td>Medical management</td>
</tr>
<tr>
<td class="label">Physical Therapist</td>
<td>Positioning, mobility</td>
</tr>
<tr>
<td class="label">Occupational Therapist</td>
<td>AAC device setup</td>
</tr>
<tr>
<td class="label">Neuropsychologist</td>
<td>Cognitive assessment</td>
</tr>
<tr>
<td class="label">Assistive Technology Specialist</td>
<td>Device configuration</td>
</tr>
<tr>
<td class="label">Audiologist</td>
<td>Hearing assessment</td>
</tr>
<tr>
<td class="label">Measure</td>
<td>Domain</td>
</tr>
<tr>
<td class="label">Maximum Phonation Time</td>
<td>Vocal function</td>
</tr>
<tr>
<td class="label">Sound Pressure Level (SPL)</td>
<td>Vocal intensity</td>
</tr>
<tr>
<td class="label">Sentence Intelligibility Test (SIT)</td>
<td>Speech intelligibility</td>
</tr>
<tr>
<td class="label">Communication Effectiveness in Daily Living</td>
<td>Functional communication</td>
</tr>
<tr>
<td class="label">Dysarthria Impact Profile</td>
<td>Quality of life</td>
</tr>
<tr>
<td class="label">Eating Assessment Tool (E-10)</td>
<td>Dysphagia</td>
</tr>
<tr>
<td class="label">Component</td>
<td>Score</td>
</tr>
<tr>
<td class="label">LSVT LOUD protocol</td>
<td>9/10</td>
</tr>
<tr>
<td class="label">Modified CBS protocols</td>
<td>8/10</td>
</tr>
<tr>
<td class="label">Modified PSP protocols</td>
<td>8/10</td>
</tr>
<tr>
<td class="label">Voice amplification</td>
<td>8/10</td>
</tr>
<tr>
<td class="label">Speech intelligibility exercises</td>
<td>7/10</td>
</tr>
<tr>
<td class="label">Low-tech AAC</td>
<td>8/10</td>
</tr>
<tr>
<td class="label">High-tech AAC</td>
<td>8/10</td>
</tr>
<tr>
<td class="label">Caregiver strategies</td>
<td>9/10</td>
</tr>
<tr>
<td class="label">Telepractice</td>
<td>7/10</td>
</tr>
<tr>
<td class="label">Total</td>
<td>72/100 (72%)</td>
</tr>
<tr>
<td class="label">Medication</td>
<td>Timing Consideration</td>
</tr>
<tr>
<td class="label">Levodopa</td>
<td>Schedule speech therapy during "on" periods</td>
</tr>
<tr>
<td class="label">Rasagiline</td>
<td>No specific interaction; monitor for fatigue</td>
</tr>
</table>
This section provides comprehensive coverage of LSVT (Lee Silverman Voice Treatment) LOUD protocols, voice amplification technologies, speech intelligibility enhancement strategies, augmentative and alternative communication (AAC) devices, and caregiver communication strategies specifically adapted for corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP). Building upon the foundational speech therapy content in [Section 113: Speech and Language Therapy](/therapeutics/section-113-speech-language-therapy-cbs-psp) and the advanced interventions in [Section 225: Advanced Speech and Communication Therapy](/therapeutics/section-225-advanced-speech-communication-therapy-cbs-psp), this section focuses specifically on the LSVT methodology and its applications for atypical parkinsonian disorders.
Voice and speech impairment is among the most disabling features of CBS and PSP, affecting up to 90% of patients and significantly impacting quality of life, social participation, and functional independence. The hypokinetic dysarthria characteristic of these disorders results in reduced vocal loudness (hypophonia), monotone pitch, impaired articulation, and reduced speech intelligibility. LSVT LOUD represents the most evidence-based voice therapy approach for parkinsonian disorders, with over 25 years of research supporting its efficacy[@ramig2021].
1. LSVT LOUD Protocol: Foundation and Evidence
1.1 Core Treatment Principles
LSVT LOUD is a speech therapy methodology specifically designed to address the voice and speech deficits characteristic of parkinsonian disorders. The treatment is based on the principle that individuals with Parkinson's disease and related disorders can improve their vocal function through intensive, repetitive exercises focused on increasing vocal loudness.
Fundamental Principles:
1.2 Standard LSVT LOUD Protocol
Standard Protocol Structure:
Session Structure:
- Sustained vowel phonation at loud target
- Pitch glides (high-low alternations)
- Maximum duration vowels
- Reading passages at loud target
- Conversation practice
- Reading functional materials (menus, grocery lists)
- Conversational speech practice
- Phone call practice
- Speech intelligibility tasks
1.3 Evidence in CBS/PSP
While LSVT LOUD was originally developed for Parkinson's disease, research has demonstrated its efficacy and applicability to atypical parkinsonian syndromes, though adaptations are often necessary:
Evidence Summary:
CBS/PSP-Specific Considerations:
- Both CBS and PSP patients show slower therapeutic gains than Parkinson's disease patients
- Modified protocols with shorter sessions and extended treatment duration may be necessary
- Cognitive impairment in CBS may limit participation in standard protocols
- Earlier initiation of LSVT appears to produce better outcomes[@fedor2016]
2. LSVT Protocol Modifications for CBS/PSP
2.1 CBS-Specific Modifications
Corticobasal syndrome presents unique challenges requiring protocol adaptations:
Fatigue Management Protocol:
Asymmetric Presentation Adaptations:
Apraxia of Speech Integration:
Many CBS patients present with concomitant apraxia of speech (AOS), requiring integrated treatment approaches:
2.2 PSP-Specific Modifications
Progressive supranuclear palsy requires distinct protocol adaptations due to its unique clinical features:
Oculomotor Considerations:
Positioning and Mobility Adaptations:
Disease Progression Adaptations:
As PSP progresses, treatment should evolve to address changing needs:
3. Voice Amplification Devices
3.1 Personal Voice Amplification Systems
Voice amplification devices provide immediate benefit for patients with hypophonia:
Amplifier Categories:
Recommended Devices for CBS/PSP:
- Chatter Vox VX-2: Portable, lightweight, good battery life
- VoiceAmp: Compact desktop option
- Sonic Modulator apps: Smartphone-based (iOS/Android)
- Smartphone volume as primary amplifier
- Headphones with microphone for remote conversations
- Speakerphone for group settings
3.2 Implementation Strategies
Amplification Training Protocol:
Daily Use Recommendations:
- Use amplification during all phone conversations
- Employ in noisy environments (restaurants, group settings)
- Use during medical appointments
- Consider during family gatherings
4. Speech Intelligibility Exercises
4.1 Articulatory Precision Training
Articulatory precision exercises address the imprecise articulation common in CBS/PSP dysarthria:
Precision Articulation Protocol:
Minimal Contrast Pairs for Practice:
4.2 Prosody and Rate Modification
Rate Control Strategies:
- Start at comfortable rate (80-100 words/minute)
- Gradually slow to 60-80 words/minute
- Use visual metronome or app for feedback
- Visual pacing aid with spaces for finger placement
- 1 word per space for moderate rate
- 1 phrase per space for severe impairment
- Device provides delayed feedback to slow speech rate
- Typical delay: 50-150ms depending on severity
- Requires tolerance for auditory feedback
4.3 Breathing and Phrasing Exercises
Proper breath support is essential for loud, clear speech:
Breathing for Speech Protocol:
- Lie on back, place hand on abdomen
- Breathe so hand rises (diaphragmatic breathing)
- Transfer to seated, then standing position
- Take normal breath for speech
- Sustain /s/ or vowel for target duration
- Target: 15-20 seconds for conversational speech
- Practice taking breaths at natural phrase boundaries
- Chunk utterances into 4-6 word phrases
- Practice with reading passages and conversation
5. Augmentative and Alternative Communication (AAC)
5.1 Low-Tech AAC Options
Low-tech AAC provides immediate, accessible communication support:
Low-Tech AAC Hierarchy:
Core Vocabulary Boards:
Core vocabulary boards contain high-frequency words and phrases:
- Greetings: Hello, good morning, how are you?
- Needs: I need, I want, please, thank you
- Pain/discomfort: Hurt, tired, uncomfortable
- Emotions: Happy, sad, frustrated, scared
- Medical: I need my medication, I need the doctor
5.2 High-Tech AAC Systems
High-tech AAC provides sophisticated communication support for advanced disease:
Recommended High-Tech Systems:
Eye Gaze Systems for PSP:
Eye gaze AAC systems are particularly valuable for PSP patients due to vertical gaze palsy progression:
5.3 AAC Assessment and Implementation
AAC Assessment Protocol:
Implementation Timeline:
6. Caregiver Communication Strategies
6.1 Environmental Modifications
Caregivers can implement environmental strategies to improve communication:
Environmental Optimization:
6.2 Communication Partner Strategies
Effective Communication Techniques:
- Maintain eye contact
- Do not interrupt
- Confirm understanding before responding
- Be patient with pauses
- Use yes/no questions when possible
- Offer choices rather than open-ended questions
- Wait 10-30 seconds for response
- Avoid testing memory
- Point to objects when discussing
- Use gestures and facial expressions
- Write key words if needed
- Use pictures when helpful
- Ask for clarification gently
- Repeat back understood portions
- Offer guesses if patient struggles
- Use backchanneling ("I understand")
6.3 Caregiver Self-Care and Training
Caregiver Training Recommendations:
Caregiver Resources:
- LSVT Global caregiver resources
- Parkinson's Foundation caregiver support
- Local speech-language pathology services
- Online caregiver communities
7. Telepractice Delivery
7.1 LSVT LOUD via Telepractice
LSVT LOUD can be effectively delivered via telepractice:
Telepractice Requirements:
Telepractice Adaptations:
Evidence for Telepractice Efficacy:
Research supports telepractice delivery of LSVT LOUD with comparable outcomes to in-person treatment. Telepractice improves access for patients with transportation barriers and mobility limitations[@theodoros2010].
7.2 Remote Monitoring and Apps
Recommended Apps for Home Practice:
8. Interdisciplinary Coordination
8.1 Team Members for LSVT and Communication Therapy
8.2 Outcome Monitoring
Recommended Outcome Measures:
9. Patient and Caregiver Action Items
9.1 Immediate Actions (0-3 months)
9.2 Short-Term Goals (3-12 months)
9.3 Long-Term Planning (12+ months)
10. NET Assessment
Relevance to CBS/PSP Patient:
11. Drug Interactions with Current Regimen
Current Medications: Levodopa, rasagiline (MAO-B inhibitor)
Speech therapy does not have direct pharmacologic interactions with the current medication regimen. However, timing of sessions relative to medication dosing affects performance:
Recommendations:
- Schedule sessions 30-60 minutes after levodopa dose
- Morning sessions may be preferable before fatigue accumulates
- Monitor for "off" periods affecting speech and respiratory function
- Document "on/off" status relative to speech performance
12. Cross-Links and Related Pages
- [Section 113: Speech and Language Therapy in CBS/PSP](/therapeutics/section-113-speech-language-therapy-cbs-psp) — Foundational speech therapy
- [Section 225: Advanced Speech and Communication Therapy](/therapeutics/section-225-advanced-speech-communication-therapy-cbs-psp) — Advanced interventions
- [CBS/PSP Rehabilitation Guide](/therapeutics/cbs-psp-rehabilitation-guide) — Comprehensive rehabilitation
- [Clinical Management Guide](/therapeutics/clinical-management-guide-cbs-psp) — Symptom management overview
- [Dysphagia Management](/diagnostics/dysphagia-management-cbs-psp) — Swallowing assessment and treatment
- [LSVT Global](/companies/lsvt-global) — LSVT organization and resources
13. References
References
See Also
Related Hypotheses:
- [Bacterial Enzyme-Mediated Dopamine Precursor Synthesis](/hypotheses/h-7bb47d7a)
- [Purinergic Signaling Polarization Control](/hypotheses/h-0758b337)
- [Mechanosensitive Ion Channel Reprogramming](/hypotheses/h-db6aa4b1)
- [Lipid Droplet Dynamics as Phenotype Switches](/hypotheses/h-7d4a24d3)
- [HCN1-Mediated Resonance Frequency Stabilization Therapy](/hypotheses/h-d40d2659)
- [4R-tau strain-specific spreading patterns in PSP vs CBD](/analysis/SDA-2026-04-01-gap-005)
- [N-of-1 Clinical Trial Design for CBS/PSP](/experiment/exp-wiki-experiments-n-of-1-clinical-trial-cbs-psp)
- [Experiment Scoring Methodology](/experiment/exp-wiki-experiments-scoring-methodology)
- [Brainstem Circuit Modulation for PSP](/experiment/exp-wiki-experiments-brainstem-circuit-modulation-psp)
Related Hypotheses
From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
- [Bacterial Enzyme-Mediated Dopamine Precursor Synthesis](/hypothesis/h-7bb47d7a) — <span style="color:#ffd54f;font-weight:600">0.44</span> · Target: TH, AADC
- [Purinergic Signaling Polarization Control](/hypothesis/h-0758b337) — <span style="color:#81c784;font-weight:600">0.74</span> · Target: P2RY1 and P2RX7
- [Mechanosensitive Ion Channel Reprogramming](/hypothesis/h-db6aa4b1) — <span style="color:#81c784;font-weight:600">0.65</span> · Target: PIEZO1 and KCNK2
- [Lipid Droplet Dynamics as Phenotype Switches](/hypothesis/h-7d4a24d3) — <span style="color:#ffd54f;font-weight:600">0.57</span> · Target: DGAT1 and SOAT1
- [CYP46A1 Overexpression Gene Therapy](/hypothesis/h-2600483e) — <span style="color:#81c784;font-weight:600">0.79</span> · Target: CYP46A1
- [Gamma entrainment therapy to restore hippocampal-cortical synchrony](/hypothesis/h-bdbd2120) — <span style="color:#81c784;font-weight:600">0.77</span> · Target: SST
- [Selective Acid Sphingomyelinase Modulation Therapy](/hypothesis/h-de0d4364) — <span style="color:#81c784;font-weight:600">0.77</span> · Target: SMPD1
- [Purinergic P2Y12 Inverse Agonist Therapy](/hypothesis/h-f99ce4ca) — <span style="color:#81c784;font-weight:600">0.71</span> · Target: P2RY12
- [4R-tau strain-specific spreading patterns in PSP vs CBD](/analysis/SDA-2026-04-01-gap-005) 🔄
- [Astrocyte reactivity subtypes in neurodegeneration](/analysis/SDA-2026-04-01-gap-007) 🔄
- [Lipid raft composition changes in synaptic neurodegeneration](/analysis/SDA-2026-04-01-gap-lipid-rafts-2026-04-01) 🔄
- [TDP-43 phase separation therapeutics for ALS-FTD](/analysis/SDA-2026-04-01-gap-006) 🔄
- [Synaptic pruning by microglia in early AD](/analysis/SDA-2026-04-01-gap-v2-691b42f1) 🔄
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | therapeutics-section-249-advanced-lsvt-voice-speech-therapy-cbs-psp |
| kg_node_id | None |
| entity_type | therapeutic |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-0c78cd1f3474 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'therapeutics-section-249-advanced-lsvt-voice-speech-therapy-cbs-psp'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-therapeutics-section-249-advanced-lsvt-voice-speech-therapy-cbs-psp?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[Section 249: Advanced LSVT Voice and Speech Therapy in CBS/PSP](http://scidex.ai/artifact/wiki-therapeutics-section-249-advanced-lsvt-voice-speech-therapy-cbs-psp)
http://scidex.ai/artifact/wiki-therapeutics-section-249-advanced-lsvt-voice-speech-therapy-cbs-psp